Kiadis Pharma Eulerpool News

Kiadis Pharma Aktie News

Kiadis Pharma wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Kiadis Pharma News stellen wir hier zusammen.

• 13. Mai ·

  Yahoo
  Notice of Annual General Meeting of Shareholders
• 29. April ·

  Yahoo
  Final results of the Offer for Kiadis: 97.39% of Kiadis Shares in total committed under the Offer
• 16. April ·

  Yahoo
  Sanofi completes Kiadis acquisition
• 30. März ·

  Yahoo
  Kiadis EGM adopts all resolutions related to the recommended public offer by Sanofi
• 24. November ·

  Yahoo
  Kiadis to present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
• 3. November ·

  Yahoo
  Sanofi Acquiring Immunotherapy Biotech Kiadis in $358 Million Deal
• 2. November ·

  Yahoo
  Sanofi offers to acquire Kiadis for €308 million
• 15. September ·

  Yahoo
  Kiadis receives $9.5 million from the Advanced Regenerative Manufacturing Institute’s BioFabUSA Program to fund Kiadis K-NK cell COVID-19 therapy
• 14. September ·

  Yahoo
  Kiadis announces U.S. FDA approval of the Abigail Wexner Research Institute at Nationwide Children’s Hospital’s IND for a COVID-19 clinical trial with off-the-shelf K-NK cells using Kiadis’ proprietary platforms
• 29. August ·

  Yahoo
  Kiadis announces new data demonstrating FC21-NK cells were well tolerated and showed encouraging signs of antitumor and suspected antimicrobial activity in 13 patients with relapsed/refractory acute myeloid leukemia (R/R AML)